SAN DIEGO, June 13, 2017 /PRNewswire/ -- Johnson & Weaver, LLP is investigating potential violations of federal and state securities laws by Endologix, Inc. (NASDAQ: ELGX) and certain of its officers.
A class action lawsuit was filed against Endologix over alleged securities laws violations. The complaint was brought on behalf of all purchasers of Endologix securities between May 5, 2016 and May 18, 2017. If you have held shares continuously before May 5, 2016, you may have standing to hold Endologix harmless from the damage the officers and directors caused by making them personally responsible. You may also be able to assist in reforming the Company's corporate governance to prevent future wrongdoing.
The Complaint filed alleges that throughout the Class Period Defendants made false and/or misleading statements and/or failed to disclose that: (1) Endologix did not have the necessary clinical data for FDA premarket approval of its Nellix® EndoVascular Aneurysm Sealing System; and (2) consequently, the Company's public statements were materially false and misled at all relevant times.
If you are an Endologix shareholder, have held shares continuously before May 5, 2016, and are interested in learning more about the investigation or your legal rights and remedies, please contact lead analyst Jim Baker (email@example.com) at 619-814-4471. If you email, please include your phone number.
About Johnson & Weaver, LLP:
Johnson & Weaver, LLP is a nationally recognized shareholder rights law firm with offices in California, New York, and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonandweaver.com. Attorney advertising. Past results do not guarantee future outcomes.
Johnson & Weaver, LLP
Jim Baker, 619-814-4471
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/endologix-alert-jw-investigates-endologix-inc-long-term-investors-encouraged-to-contact-the-firm-300473036.html
SOURCE Johnson & Weaver, LLP